Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF-Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next-Generation Sequencing, and Fragmentomics.

Case Rep Oncol Med · 2025 · PMC12618127 · PMID 41245504

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Fragmentomics analysis of our patient's plasma by WGS found a decreasing trend in CCCA from predoublet treatment to progression on doublet and triplet, respectively.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.